Search
Now showing items 1-2 of 2
Attenuating regulatory T cell induction by TLR agonists through inhibition of p38 MAPK signaling in dendritic cells enhances their efficacy as vaccine adjuvants and cancer immunotherapeutics
(The American Association of Immunologists, 2008)